How Big Is the Drug Screening Market?
According to 6Wresearch internal database and industry insights, the
Global Drug Screening Market was valued at USD 7.9 Billion in 2024 and is expected to reach USD 14.6 Billion by 2031, growing at a compound annual growth rate of 10.38% during the forecast period (2025-2031).
This growth is a result of stringent workplace drug testing policies, an increase in demand for rapid-testing kits, and growing government initiatives in the U.S., Europe, and some parts of Asia-Pacific.
Growth Drivers of the Drug Screening Market
- More enforcement of workplace compliance on employee drug testing
- Growth in substance abuse worldwide and increased costs of healthcare
- Advancements in technology for faster and non-invasive drug testing
- Increasing awareness from employers, law enforcement, and educational institutions
- Increasing legalization of cannabis in different areas, which leads to more possible drug testing protocols
- Government mandated drug testing in safety sensitive industries
Drug Screening Market Trends
Drug Screening Market is focusing on more oral fluid and hair drug testing, increased use of artificial intelligence (AI)-based screening devices in laboratories, and greater demand for home drug testing kits. The Drug Screening Market is also focusing on automated analyzers and greater utilization of integrated LIMS systems to handle high-volume testing in forensic labs and clinics.
Emerging Developments in Drug Screening Market
The Drug Screening Market is progressing swiftly on several fronts as there are ever-increasing pressures for rapid, greater accuracy, and less invasive testing. Emerging technologies include point-of-care testing devices, mobile drug testing kits, and the increasing adoption of saliva, hair, and breath-based testing, which offer greater convenience and extended detection windows. High-throughput platforms using mass spectrometry and liquid chromatography are enabling precise detection of a wider range of substances, including synthetic and designer drugs.
Leading Companies in the Drug Screening Industry
- Abbott Laboratories
- Quest Diagnostics
- Alere (a subsidiary of Abbott)
- Thermo Fisher Scientific
- OraSure Technologies
- LabCorp
- Psychemedics Corporation
How big is the Drug Screening Market : FAQ's
The market was valued at USD 7.9 Billion in 2024 and is expected to reach USD 14.6 Billion by 2031,
Emerging tools include biosensor-based devices, AI-driven result analysis, and mobile-enabled real-time testing kits.
Industries like transportation, construction, manufacturing, sports, and healthcare have high demand due to safety-critical operations.
Governments globally are supporting anti-drug campaigns, enforcing testing laws, and funding rehabilitation-linked testing programs to curb addiction.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com